Figure 1From: Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinomaHigh normal platelets and thrombocytosis are associated with worse overall survival. (log-rank p < 0.0001).Back to article page